As of 2025-11-05, the Relative Valuation of Solid Biosciences Inc (SLDB) is (18.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.93 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -574.5%.
The range of the Relative Valuation is (14.09) - (25.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 12.7x | 8.7x |
| Forward P/E multiples | 7.1x - 13.2x | 10.1x |
| Fair Price | (14.09) - (25.05) | (18.65) |
| Upside | -458.5% - -737.4% | -574.5% |
| Date | P/E |
| 2025-11-05 | -1.99 |
| 2025-11-04 | -2.23 |
| 2025-11-03 | -2.63 |
| 2025-10-31 | -2.72 |
| 2025-10-30 | -2.68 |
| 2025-10-29 | -2.77 |
| 2025-10-28 | -2.99 |
| 2025-10-27 | -2.98 |
| 2025-10-24 | -2.84 |
| 2025-10-23 | -2.79 |
| 2025-10-22 | -2.85 |
| 2025-10-21 | -3.04 |
| 2025-10-20 | -3.11 |
| 2025-10-17 | -2.97 |
| 2025-10-16 | -3.11 |
| 2025-10-15 | -3.19 |
| 2025-10-14 | -3.15 |
| 2025-10-13 | -3.04 |
| 2025-10-10 | -3.01 |
| 2025-10-09 | -3.23 |
| 2025-10-08 | -3.19 |
| 2025-10-07 | -2.79 |
| 2025-10-06 | -2.77 |
| 2025-10-03 | -2.98 |
| 2025-10-02 | -2.90 |
| 2025-10-01 | -2.97 |
| 2025-09-30 | -3.12 |
| 2025-09-29 | -3.02 |
| 2025-09-26 | -3.11 |
| 2025-09-25 | -2.99 |
| 2025-09-24 | -3.15 |
| 2025-09-23 | -2.69 |
| 2025-09-22 | -2.61 |
| 2025-09-19 | -2.59 |
| 2025-09-18 | -2.75 |
| 2025-09-17 | -2.76 |
| 2025-09-16 | -2.73 |
| 2025-09-15 | -2.77 |
| 2025-09-12 | -2.72 |
| 2025-09-11 | -2.68 |
| 2025-09-10 | -2.65 |
| 2025-09-09 | -2.53 |
| 2025-09-08 | -2.59 |
| 2025-09-05 | -2.78 |
| 2025-09-04 | -2.81 |
| 2025-09-03 | -2.91 |
| 2025-09-02 | -2.74 |
| 2025-08-29 | -2.77 |
| 2025-08-28 | -2.84 |
| 2025-08-27 | -2.84 |